APA (7th ed.) Citation

J, S., Z, S., L, H., S, W., P, Z., N, S., & C, Y. (2025). ASO Author Reflections: SMARCA4 Deficiency as a Potential Biomarker for Adjuvant Therapy in Pulmonary Large Cell Carcinoma. Annals of surgical oncology, 32(9), 7095. https://doi.org/10.1245/s10434-025-17615-z

Chicago Style (17th ed.) Citation

J, Sun, Shen Z, Han L, Wan S, Zhang P, Song N, and Ye C. "ASO Author Reflections: SMARCA4 Deficiency as a Potential Biomarker for Adjuvant Therapy in Pulmonary Large Cell Carcinoma." Annals of Surgical Oncology 32, no. 9 (2025): 7095. https://doi.org/10.1245/s10434-025-17615-z.

MLA (9th ed.) Citation

J, Sun, et al. "ASO Author Reflections: SMARCA4 Deficiency as a Potential Biomarker for Adjuvant Therapy in Pulmonary Large Cell Carcinoma." Annals of Surgical Oncology, vol. 32, no. 9, 2025, p. 7095, https://doi.org/10.1245/s10434-025-17615-z.